Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00365950
Status:
COMPLETED
Last Update Posted:
2006-08-18
First Post:
2006-08-17
Brief Title:
3 Months Versus 6 Months Anticoagulation in Patients With DVT andor PE
Sponsor:
British Thoracic Society
Organization:
British Thoracic Society
Study Overview
Official Title:
Clinical Trial of Two Durations of Warfarin Therapy in the Treatment of Deep Vein Thrombosis andor Pulmonary Embolism
Status:
COMPLETED
Status Verified Date:
2004-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine whether 3 months anticoagulation is as good as or better than 6 months for the treatment of DVTPE
Detailed Description:
Multi-centre trial involving 46 hospitals in the United Kingdom with patients entered by 137 Consultant Physicians Consenting patients were randomised in a central office to either 3 months or 6 months anticoagulation Information on progress of the patients was requested by the co-ordinating office at 3 months 6 months and 12 months Outcomes were measured as death from DVTPE non-fatal extensions or recurrences of DVTPE and major haemorrhages during and after anticoagulation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None